Total medical devices industry M&A deals in January 2019 worth $1.51bn were announced globally, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked an increase of 165.2% over the previous month and a drop of 42.7% when compared with the last 12-month average, which stood at $2.64bn.
Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $1.41bn. At the country level, the United States topped the list in terms of deal value at $1.41bn.
In terms of volumes, North America emerged as the top region for medical devices M&A deals globally, followed by Asia-Pacific and then Europe.
The top country in terms of M&A deals activity in January 2019 was the United States with 21 deals, followed by Israel with three and Canada with two.
Medical devices industry M&A deals in January 2019: Top deals
The top five medical devices industry M&A deals accounted for 99.05% of the overall value during January 2019.
The combined value of the top five medical devices M&A deals stood at $1.5bn, against the overall value of $1.51bn recorded for the month.
The top announced medical devices M&A deal tracked by GlobalData in January 2019 was PHC’s $1.14bn asset transaction with Thermo Fisher Scientific.
In second place was Qiagen’s asset transaction with Formulatrix for $260m and in third place was BioTelemetry’s $65m acquisition of Geneva Healthcare.
Advanced Medical Solutions Group’s $25m acquisition of Sealantis and Medicure’s acquisition of Sensible Medical Innovations for $10m held fourth and fifth positions, respectively.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.